SCHEDULE 13G

Company

Pasithea Therapeutics Corp.

Filed

November 4, 2021

Accession Number

0001213900-21-056744

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →